The following drug updates are listed by booklet title. This information is not found in the current version of these booklets, as these treatments were not FDA approved at the time the books were published.
Acute Lymphoblastic Leukemia (ALL ) in Adults
and
Acute Lymphoblastic Leukemia (ALL) in Children and Teens
and
The ALL Guide: Information for Patients and Caregivers
- Update on Page 54 of Acute Lymphoblastic Leukemia in Adults: Inotuzumab ozogamicin (Besponsa®) is administered intravenous (IV) and is FDA approved for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Acute Myeloid Leukemia (AML) in Adults
and
Acute Myeloid Leukemia (AML) in Children and Teens
and
The AML Guide: Information for Patients and Caregivers
No updates
Chronic Lymphocytic Leukemia
and
The CLL Guide: Information for Patients and Caregivers
No updates
Chronic Myeloid Leukemia
and
The CML Guide: Information for Patients and Caregivers
No updates